This comes just under a month after Pfizer finalised a deal to acquire Metsera following a bidding war with Novo Nordisk.

Nova Pneuma Inc. ("NPI"), the Delaware incorporated and wholly owned subsidiary of Lee's Pharmaceutical Holdings Limited ...

Inductive Bio has secured up to $21m in funding from ARPA-H to lead the development of AI drug-toxicity prediction models.

Just a year after the first AI-designed protein was made, scientists are preparing for clinical trials testing AI-designed ...

The U.S. Food and Drug Administration has qualified the first AI tool designed to help doctors assess a severe form of fatty ...

Counterfeit pharmaceuticals jeopardize public health worldwide, often leading to ineffective or dangerous treatments. Enter ...

Intellicule has received a $217,941 NIH SBIR Phase I grant to develop advanced deep-learning software for biomolecular ...

With the Technology-Enabled Meaningful Patient Outcomes initiative, some digital health developers will offer devices for ...

Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are uninsured and underinsured and whose out-of-pocket costs exceed Brenzavvy‘s cash ...

Doctors have discovered that a new groundbreaking therapy has reversed incurable blood cancers in some patients.A therapy, ...

The Emirates Drug Establishment (EDE), in collaboration with the Drug Information Association (DIA), Middle East and Africa Office, organised the first Clinical Research Forum in the UAE at the ...

NVision Polaris hyperpolarization technology to be utilized in preclinical research for more rapid and precise cancer diagnosis and treatment monitoring NVision Imaging Technologies (NVision), develop ...